$17.75
0.33[1.89%]
Last update: 9:43AM Get Real Time Here
Silk Road Medical
(NASDAQ:SILK)Silk Road Medical Stock (NASDAQ:SILK), Analyst Ratings, Price Targets, Predictions
Silk Road Medical Inc has a consensus price target of $23.46, established from looking at the 38 latest analyst ratings. The last 3 analyst ratings were released from Argus Research, Stifel, and JP Morgan on March 7, 2024, February 29, 2024, and February 29, 2024. With an average price target of $22 between Argus Research, Stifel, and JP Morgan, there's an implied 23.94% upside for Silk Road Medical Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Argus Research
Stifel
JP Morgan
Piper Sandler
Lake Street
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Silk Road Medical
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 03/07/2024 | SILK | Buy Now | Silk Road Medical | $17.75 | 35.21% | Argus Research | Steve Silver | → $24 | Upgrade | Hold → Buy | Get Alert |
| 02/29/2024 | SILK | Buy Now | Silk Road Medical | $17.75 | 29.58% | Stifel | Rick Wise | $20 → $23 | Maintains | Buy | Get Alert |
| 02/29/2024 | SILK | Buy Now | Silk Road Medical | $17.75 | 7.04% | JP Morgan | Robbie Marcus | $10 → $19 | Maintains | Neutral | Get Alert |
| 02/29/2024 | SILK | Buy Now | Silk Road Medical | $17.75 | 1.41% | Piper Sandler | Adam Maeder | $11 → $18 | Maintains | Neutral | Get Alert |
| 01/19/2024 | SILK | Buy Now | Silk Road Medical | $17.75 | 12.68% | Stifel | Rick Wise | $9 → $20 | Upgrade | Hold → Buy | Get Alert |
| 01/03/2024 | SILK | Buy Now | Silk Road Medical | $17.75 | 12.68% | Lake Street | Frank Takkinen | → $20 | Initiates | → Buy | Get Alert |
| 10/24/2023 | SILK | Buy Now | Silk Road Medical | $17.75 | — | Wolfe Research | Mike Polark | — | Upgrade | Underperform → Peer Perform | Get Alert |
| 10/11/2023 | SILK | Buy Now | Silk Road Medical | $17.75 | -38.03% | Piper Sandler | Adam Maeder | $25 → $11 | Maintains | Neutral | Get Alert |
| 10/11/2023 | SILK | Buy Now | Silk Road Medical | $17.75 | — | CL King | Kristen Stewart | — | Downgrade | Buy → Neutral | Get Alert |
| 10/11/2023 | SILK | Buy Now | Silk Road Medical | $17.75 | -54.93% | Citigroup | Joanne Wuensch | $35 → $8 | Downgrade | Buy → Sell | Get Alert |
| 10/11/2023 | SILK | Buy Now | Silk Road Medical | $17.75 | -21.13% | B. Riley Securities | Neil Chatterji | $54 → $14 | Downgrade | Buy → Neutral | Get Alert |
| 10/11/2023 | SILK | Buy Now | Silk Road Medical | $17.75 | -32.39% | Stifel | Rick Wise | $45 → $12 | Downgrade | Buy → Hold | Get Alert |
| 09/21/2023 | SILK | Buy Now | Silk Road Medical | $17.75 | — | Argus Research | Steve Silver | — | Downgrade | Buy → Hold | Get Alert |
| 09/06/2023 | SILK | Buy Now | Silk Road Medical | $17.75 | 69.01% | Oppenheimer | Suraj Kalia | → $30 | Initiates | → Outperform | Get Alert |
| 08/14/2023 | SILK | Buy Now | Silk Road Medical | $17.75 | 97.18% | Citigroup | Joanne Wuensch | $48 → $35 | Maintains | Buy | Get Alert |
| 08/02/2023 | SILK | Buy Now | Silk Road Medical | $17.75 | 204.23% | B. Riley Securities | Neil Chatterji | $58 → $54 | Maintains | Buy | Get Alert |
| 08/02/2023 | SILK | Buy Now | Silk Road Medical | $17.75 | 153.52% | Stifel | Rick Wise | $50 → $45 | Maintains | Buy | Get Alert |
| 07/12/2023 | SILK | Buy Now | Silk Road Medical | $17.75 | 57.75% | B of A Securities | Travis Steed | $51 → $28 | Downgrade | Buy → Underperform | Get Alert |
| 07/12/2023 | SILK | Buy Now | Silk Road Medical | $17.75 | 57.75% | JP Morgan | Robbie Marcus | $50 → $28 | Downgrade | Overweight → Neutral | Get Alert |
FAQ
What is the target price for Silk Road Medical (SILK)?
The latest price target for Silk Road Medical (NASDAQ: SILK) was reported by Argus Research on March 7, 2024. The analyst firm set a price target for $24.00 expecting SILK to rise to within 12 months (a possible 35.21% upside). 25 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Silk Road Medical (SILK)?
The latest analyst rating for Silk Road Medical (NASDAQ: SILK) was provided by Argus Research, and Silk Road Medical upgraded their buy rating.
When was the last upgrade for Silk Road Medical (SILK)?
The last upgrade for Silk Road Medical Inc happened on March 7, 2024 when Argus Research raised their price target to $24. Argus Research previously had a hold for Silk Road Medical Inc.
When was the last downgrade for Silk Road Medical (SILK)?
The last downgrade for Silk Road Medical Inc happened on October 11, 2023 when CL King changed their price target from N/A to N/A for Silk Road Medical Inc.
When is the next analyst rating going to be posted or updated for Silk Road Medical (SILK)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Silk Road Medical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Silk Road Medical was filed on March 7, 2024 so you should expect the next rating to be made available sometime around March 7, 2025.
Is the Analyst Rating Silk Road Medical (SILK) correct?
While ratings are subjective and will change, the latest Silk Road Medical (SILK) rating was a upgraded with a price target of $0.00 to $24.00. The current price Silk Road Medical (SILK) is trading at is $17.75, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.